Aeglea BioTherapeutics Inc

NASDAQ:AGLE   1:04:47 PM EDT
0.53
+0.01 (+1.83%)
Earnings Announcements

Aeglea Bio Reports Q2 Loss Per Share Of $0.27

Published: 08/04/2022 11:43 GMT
Aeglea BioTherapeutics Inc (AGLE) - Aeglea Biotherapeutics Reports Second Quarter 2022 Financial Results and Provides Program Updates.
Qtrly Loss per Share $0.27.
Q2 Earnings per Share View $-0.31 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.16 Million
Adjusted EPS is expected to be -$0.27

Next Quarter Revenue Guidance is expected to be $0.16 Million
Next Quarter EPS Guidance is expected to be -$0.28

More details on our Analysts Page.